As Global Head of Oncology for IQVIA Biotech, Gerhard du Toit manages all aspects of oncology clinical trials, optimising ...
Interim results from the ongoing GLISTEN trial of linerixibat, GSK's targeted inhibitor of the ileal bile acid transporter ...
Researchers from the National Institutes of Health (NIH) are applying artificial intelligence to the recruitment of ...
Mendelsohn – using history as a guide – suggests there will be a layering of new laws, with, for example, a push for changes ...
Top-line results show that 64.7% of patients achieved clear or almost clear skin measured using the Investigator's Global ...
"Astellas stands by the clinical profile of Izervay, the only FDA-approved GA treatment that consistently demonstrated ...
Grifols is anticipating a period of strong growth on the back of its recently FDA-approved intravenous immunoglobulin product ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback